About Progressive myoclonic epilepsy type 5
Progressive myoclonic epilepsy type 5 is a rare disease catalogued by Orphanet (ORPHA:402082). It is associated with the PRICKLE2, POLG genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Progressive myoclonic epilepsy type 5 trials.
Search ClinicalTrials.gov for "Progressive myoclonic epilepsy type 5" or filter by Orphanet code ORPHA:402082 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Progressive myoclonic epilepsy type 5 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Progressive myoclonic epilepsy type 5. Updated daily.